[go: up one dir, main page]

GB2151921B - Controlled release form of ketoprofen for oral administration - Google Patents

Controlled release form of ketoprofen for oral administration

Info

Publication number
GB2151921B
GB2151921B GB08431987A GB8431987A GB2151921B GB 2151921 B GB2151921 B GB 2151921B GB 08431987 A GB08431987 A GB 08431987A GB 8431987 A GB8431987 A GB 8431987A GB 2151921 B GB2151921 B GB 2151921B
Authority
GB
United Kingdom
Prior art keywords
ketoprofen
oral administration
controlled release
release form
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08431987A
Other versions
GB2151921A (en
GB8431987D0 (en
Inventor
Raymond Bentejac
Michel Veillard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc Sante SA
Original Assignee
Rhone Poulenc Sante SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante SA filed Critical Rhone Poulenc Sante SA
Publication of GB8431987D0 publication Critical patent/GB8431987D0/en
Publication of GB2151921A publication Critical patent/GB2151921A/en
Application granted granted Critical
Publication of GB2151921B publication Critical patent/GB2151921B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
GB08431987A 1983-12-21 1984-12-19 Controlled release form of ketoprofen for oral administration Expired GB2151921B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8320470A FR2556965B1 (en) 1983-12-21 1983-12-21 NEW GALENIC FORM OF CONTROLLED RELEASE KETOPROFEN

Publications (3)

Publication Number Publication Date
GB8431987D0 GB8431987D0 (en) 1985-01-30
GB2151921A GB2151921A (en) 1985-07-31
GB2151921B true GB2151921B (en) 1988-08-03

Family

ID=9295398

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08431987A Expired GB2151921B (en) 1983-12-21 1984-12-19 Controlled release form of ketoprofen for oral administration

Country Status (3)

Country Link
JP (1) JPH0635383B2 (en)
FR (1) FR2556965B1 (en)
GB (1) GB2151921B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0212746B1 (en) * 1985-08-16 1991-04-10 The Procter & Gamble Company Drug particles having constant release
EP0212745B1 (en) * 1985-08-16 1991-04-10 The Procter & Gamble Company Drug particles having constant release
GB8616669D0 (en) 1986-07-09 1986-08-13 Merk Sharpe & Dohme Ltd Pharmaceutical compositions
EP0325086A3 (en) * 1987-11-23 1990-10-31 Jago Research Ag Novel methods for obtaining therapeutic systems with controlled release of the drug
JP2727009B2 (en) * 1989-03-10 1998-03-11 ダイト株式会社 Sustained preparation
FR2667242B1 (en) * 1990-09-28 1994-11-25 Rhone Poulenc Sante NEW ORAL FORMES WITH EXTENDED RELEASE WITH LATENCY TIME AT LOWERED STOMACAL LEVEL.
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US5843479A (en) * 1993-02-26 1998-12-01 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5651983A (en) * 1993-02-26 1997-07-29 The Procter & Gamble Company Bisacodyl dosage form for colonic delivery
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
CN102813638A (en) * 2011-06-07 2012-12-12 贵阳医学院 Preparation method of dexketoprofen trometamol double-layer sustained-release tablets
WO2024184796A1 (en) * 2023-03-06 2024-09-12 Welfare Concepts Limited Sustained release solid oral bolus

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3247066A (en) * 1962-09-12 1966-04-19 Parke Davis & Co Controlled release dosage form containing water-swellable beadlet
US3909444A (en) * 1971-08-05 1975-09-30 Ncr Co Microcapsule
ZA765931B (en) * 1975-10-10 1977-09-28 Squibb & Sons Inc Controlled release tablet
EP0013131A3 (en) * 1978-12-27 1981-01-07 Mundipharma A.G. Pharmaceutical composition in solid dosage form, and process for its production
FI63335B (en) * 1979-02-02 1983-02-28 Orion Yhtymae Oy FARING REFERENCE FOR A TABLETTER WITH A LIGHT LIGHT OF AN EFFECTIVE
IT1168014B (en) * 1981-08-05 1987-05-20 Erba Farmitalia PHARMACEUTICAL FORMS WITH PROTRACTED SALE
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose

Also Published As

Publication number Publication date
JPS60132915A (en) 1985-07-16
FR2556965B1 (en) 1986-08-22
JPH0635383B2 (en) 1994-05-11
GB2151921A (en) 1985-07-31
FR2556965A1 (en) 1985-06-28
GB8431987D0 (en) 1985-01-30

Similar Documents

Publication Publication Date Title
DE3464694D1 (en) Apparatus for the oral administration of capsules to animals
ZA849373B (en) Method and composition for the preparation of controlled longacting pharmaceuticals for oral administration
PT83756A (en) Process for the manufacture of controlled release pharmaceutical compositions
EP0202051A3 (en) Therapeutic compositions for oral administration
EP0205336A3 (en) Oral sustained release pharmaceutical preparation
PT83508A (en) Process for the preparation of pharmaceutical compositions with controlled release
ZA837307B (en) Oral dosage form
IL71967A (en) Drug administration composition
DK163959C (en) PHARMACEUTICAL PREPARATION FOR ORAL ADMINISTRATION CONTAINING CIMETIDIN
GB2120937B (en) Implant for sustained release of pharmaceutical agents
GB2151921B (en) Controlled release form of ketoprofen for oral administration
GB2155335B (en) Device for sustained release of medicinal substances
ZA8410045B (en) Delayed-action acetylsalicyclic acid formulations for oral administration
PH17765A (en) Oral composition comprising ng-acyl derivatives of arginine
ZA82361B (en) Pharmaceutical composition for treating diseases of the oral cavity
DE3461053D1 (en) Articulator for dentistry
AU1656983A (en) Medicinal diphosphonic acid derivatives
EP0064388A3 (en) Process for the preparation of retard oral pharmaceutical compositions
EP0302263A3 (en) Therapeutic composition for combatting aids
GB2190287B (en) Controlled release ketoprofen pharmaceutical formulation
IL71470A0 (en) Novel galenic forms of sulpirid suitable for oral administration and their preparation
DE3375452D1 (en) Articulator for dentistry
PT76785A (en) Anti-androgenic preparation for oral cavity administration
BG43202A1 (en) Solid oral therapeutic form containing silimarin
JPS6466144A (en) Manufacture of ketoprofen

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Effective date: 20041218